Table 2 Frequencies of positive antibody indexes (AIs) for MRZ
Study group | RDwCNS(n = 23) | MS(n = 46) | OIND (n = 48) | Comparison statistics |
|---|---|---|---|---|
Patients with 0 positive AI | 87.0% | 17.4% | 77.1% | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.0001. |
Patients with 1 positive AI | 4.3% | 19.6% | 14.6% | All comparisons: n.s. |
Patients with 2 positive AIs | 8.7% | 28.3% | 6.3% | Both groups vs. RDwCNS: n.s. OIND vs. MS: p < 0.01 |
Patients with 3 positive AIs | 0% | 34.8% | 2.1% | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.001. |
Positive AIs for M | 8.7% | 63.0% | 6.3% | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.0001. |
Positive AIs for R | 4.3% | 63.0% | 12.5% | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.0001. |
Positive AIs for Z | 8.7% | 54.3% | 14.6% | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.0001. |
Mean AI values for M (range; SD) | 1.1 (0.6–2.0; 0.3) | 4.0 (0.6–52.2; 7.6) | 1.0 (0.6–2.6; 0.3) | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.0001. |
Mean AI values for R (range; SD) | 1.1 (0.6–3.6; 0.6) | 3.4 (0.7–19.8; 4.2) | 1.2 (0.6–8.3; 1.2) | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.0001. |
Mean AI values for Z (range; SD) | 1.2 (0.6–4.2; 0.7) | 3.9 (0.6–25.4; 5.2) | 1.2 (0.4–3.8; 0.6) | RDwCNS vs. OIND: n.s. Both groups vs. MS: p < 0.01. |